Validity of biopsy-based drug effects in a diet-induced obese mouse model of biopsy-confirmed NASH
Maria Nicoline Baandrup Kristiansen(Gubra (Denmark)), Jacob Jelsing(Gubra (Denmark)), Christina Christoffersen(University of Copenhagen), Jonathan D. Roth(Rutgers, The State University of New Jersey), Niels Vrang(Gubra (Denmark)), Mary Erickson(Intercept Pharmaceuticals (United States)), Luciano Adorini(Intercept Pharmaceuticals (United States)), Sanne Skovgård Veidal(Gubra (Denmark)), Michael Feigh(Gubra (Denmark))
Cited by 15
Related Papers
Efficacy of Obeticholic Acid in Patients With Primary Biliary Cirrhosis and Inadequate Response to Ursodeoxycholic Acid
|Gastroenterology|2014|563
Leptin responsiveness restored by amylin agonism in diet-induced obesity: Evidence from nonclinical and clinical studies
|Proceedings of the National Academy of Sciences|2008|433
Amylin: Pharmacology, Physiology, and Clinical Potential
|Pharmacological Reviews|2015|395
Restructuring of the Gut Microbiome by Intermittent Fasting Prevents Retinopathy and Prolongs Survival in <i>db/db</i> Mice
|Diabetes|2018|385
Diet-induced mouse model of fatty liver disease and nonalcoholic steatohepatitis reflecting clinical disease progression and methods of assessment
|American Journal of Physiology-Gastrointestinal and Liver Physiology|2013|294